MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.
Xin-Ping YuLei WangHai-Yang YuYu-Wei ZouChang WangJin-Wen JiaoHao HongShuai ZhangPublished in: Cancer management and research (2021)
MDCT-based radiomics features could be used as biomarkers for the differentiation of SBOTs and SMOTs.